MATERIALS: 1.1XPBS(PBSAz,1XPBS,e.g.,IrvineScientific,CA,containing2%newborncalfserumand0.1%sodiumazide) 2.7-Amino-actinomycinD(7-AAD,e.g.,Calbiochem,CA) 3.HumanABserum,heat-inactivated(HAB,e.g.,IrvineScientific,CA) 4.Refrigeratedcentrifuge Preparationof7-AADstocksolution Dissolve7-AADpowder(1mg)firstin50microlitersofabsolutemethanol,thenadd950microlitersof1XPBS.Finalconcentrationis1mg/ml.Keepsolutionat4°Cprotectedfromlight.Solutioncanbestoredforatleastupto6months. METHOD: Principle: Apoptoticcells,probablyduetoachangeinmembranepermeABIlity,takeupsome7-AADandbecome7-AADdimcomparedtolivecellswhichremain7-AAD-.Lateapoptoticornecroticcellswhichhavelostmembraneintegrityappear7-AADbright. Reference:SchmidI,UittenbogaartCH,KeldB,andGiorgiJV:Arapidmethodformeasuringapoptosisanddual-colorimmunofluorescencebysinglelaserflowcytometry.JImmunolMeth170:145-157,1994. Stainingfordetectionofapoptosis 1x106PBSAz-washedcellsfromasinglecellsUSPensionarepelletedina12X75mmculturetube.Thepelletisresuspendedin1mlof1XPBSAzcontaining20micrograms/mlof7-AADandthesuspensionismixedgently.Afterapproximately20minofincubationat4°Cinthedark,thesamplescanberunontheflowcytometerintheirstainingsolution.Theyshouldbekeptcoldduringacquisitionandshouldberunwithin1haftertheadditionof7-AAD,otherwisecellsshouldbefixed. Note:itispossIBLetofixcellsstainedwith7-AADfordetectionofapoptosiswitha1%formaldehydesolutioncontaining20micrograms/mlofactinomycinD(AD,C1,e.g.,BoehringerMannheim)forbiohazardconsiderationsand/ortopreservesamplesforlateranalysisontheflowcytometer.Forprocedureseeattachedprotocol. Thisstainingprocedureallowsthecorrelationofapoptosiswithsingleordual-colorphenotypeandtheuseofFITCand/orPEconjugatedmonoclonalantibodies.Surfaceantigenstainingisdoneaccordingtostandardmethodsbeforestainingforapoptosis.Then,theapoptosisassayisperformedasdescribedabove. DirectStainingProcedure 1.Resuspendcellpelletfirstin50microlitersofHABforapproximately1min,thenadd50microlitersofPBSAzandtheappropriateamountofFluorochrome-conjugatedmonoclonalantibody(mAb). 2.Vortexbrieflyandincubatefor15minat4°Cinthedark. 3.Washoncewith2mlsofPBSAzbycentrifugationat250gfor5minutes. 4.Proceedwithstainingforapoptosisasdescribedabove. IndirectStainingProcedure 1-3Processsamplesasaboveusingaworkingdilutionofunlabelledantibody. 4.Resuspendcellpelletfirstin50microlitersofHABforapproximately1min,thenadd50microlitersofaworkingdilutionofthefluorochrome-conjugatedsecondantibody. 5.Vortexbrieflyandincubatefor20minat4°Cinthedark. 6.Washoncewith2mlsofPBSAzbycentrifugationat250gfor5min. 7.Proceedwithstainingforapoptosisasdescribedabove. Note:donotuseHABforstainingofimmunoglobulinchains.Wheneveravailable,useamonoclonalantibodyand/orareagentdirectlyconjugatedtoafluorochrometominimizeunspecificbinding.Alwaysuseisotypiccontrolsofthesameheavychainclassasyourrelevantantibodyfordeterminationofbackgroundstaining. I.Materials: 1.ActinomycinD(AD,C1,e.g.,BoehringerMannheim,IN) 2.1XPBS 3.Sonicator 4.Formaldehydesolution(seeprotocolforpreparationof2%stockformaldehydesolution) II.PreparationofADstocksolution(1mg/ml): To1mgofADpowderadd: 50microlitersoficecoldabsoluteETOH,vortex 950microlitersof1XPBS Sonicatetheresultingsolutionfor10minat4°C;keepthesolutionovernightintherefrigeratorat4°C,protectedfromlightbeforeusingit. Storesolutionat4°Cprotectedfromlight. Workingdilutionis20micrograms/ml. III.Method: Cellsarefirstincubatedwith7-AADforatleast20min,thentheyarespundownonceandimmediatelya1%formaldehydesolutioncontaining20microliters/mlofAD(F/AD)isaddedtothecellpellet.Cellshavetobestoredinthecoldprotectedfromlightandcanbeanalyzedapproximately30minaftertheadditionoftheF/ADsolution.CellsarerunontheflowcytometerintheF/ADsolution.Wehavestoredsamplesupto3dayswithoutanylossintheabilitytodiscriminateearlyapoptoticfromlivecellsandlateapoptoticornecroticcells. INFORMATIONANDREFERENCESONDETECTIONOFAPOPTOTICCELLSBYFLOWCYTOMETRY ComparedtotheclassicmethodsofDNAladderformationbygelelectrophoresisandofmorphologicexaminationbyelectronmicroscopyfordeterminationofapoptosis,flowcytometrypermitsrapidandquantitativemeasurementsonapoptoticcells.Manydifferentflowcytometricmethodsfortheassessmentofapoptosisincellshavebeendescribed(forareviewsee1);mostofthesemethodsmeasureapoptoticchangesincellsbystainingwithvariousDNAdyes,however,techniquesusingtheterminaldeoxynucleotidyltransferaseornicktranslationassayshavealsobeendeveloped(3).Someofthesestainingmethodsutilizeunfixedcells(2,4,5,7,8,9,10,11).Duetothefragilityofcellsundergoingprogrammedcelldeath,rapidmethodsthatmaintaincellsascloseaspossibletotheirnaturalstatemightbeexpectedtoprovidethemostreliableresults.Thecurrentrapid7-AADstainingmethodusesunfixedcellsandthuspermitsthedetectionofchangesinlightscatterparametersandtheircorrelationwithotherindicatorsofprogrammedcelldeath.However,onedrawbackofusinganylivestainingmethodformeasuringapoptosisisthevariabilityofdyeuptakeindifferentcellsanditspossiblechangethroughcertaintreatmentconditions.FurThermore,reagentswhichaffectmembranepermeability(e.g.calciumionophores)cannotbeusedwiththistechnique. ManystainingmethodsforflowcytometryuseeitherfixedcellsortreatcellswithahypotonicsolutiontopermitDNAstainingbynon-vitaldyes.TheapoptoticcellswithdegradedDNAappearascellswithhypodiploidDNAcontentandarerepresentedinso-called"sub-G1"peaksonDNAhistograms(6,12).Telfordet.al.(12)showedonmurinethymocytesthatmanydifferentDNAdyesproducesimilardistributionsof"sub-G1"peaksirrespectiveoftheirbindingmodewhenthesamecellfixationmethodwasused.However,whenwetriedtoapplythehypotonicPImethodbyNicolettietal.(6)tohumanthymocytesourresultsindicatedthatuseofdissimilarsamplepreparationmethods(e.g.livestainingwithHO342vs.hypotonicPI)canleadtodramaticdifferencesintheabilitytodetectapoptoticcells.Undercertainconditions,thetreatmentofhumanthymocyteswithhypotoniccitratesolutioncontainingdetergentmaynotpermitleakageofthelowmolecularweightDNAoutofapoptoticcells;thisleakagehasbeenproposedasapre-requisitefortheformationof"sub-G1"peaks(1).Inmurinethymocytes,however,thehypotonicPIstainingmethodproducesacleardistinctionbetweenliveandapoptoticcells(6). Recently,ithasbeenpostulatedthatthestabilityandthekineticsofintermediatecelldeathstagesmaydeterminetheresistanceofaparticularcelltypetoDNAdegradation.Consequently,thevisibilityof"sub-G1"peaksbyflowcytometryandalsotheformationofcharacteristicDNAladdersonagarosegelsmightbeafunctionofindividualcellularhomeostasis.Theabsenceofa"sub-G1"peakonaDNAhistogramshouldnotconstituteproofofnoapoptosis(1).Conversely,ithasalsobeenstatedthatthemereappearanceofahypodiploidDNApeakshouldnotbetakenasdefiniteevidenceforthepresenceofanapoptoticcellpopulationwithoutothersupportinginformation(7).Flowcytometricfindingsinaparticularcelltypeexposedtoacertainstimulusmustthereforebealwaysverifiedwithothernon-flowcytometricmethods.Recently,rapidflowcytometricstainingmethodsthatuseAnnexinVfordetectionofphosphatidylserineexposureonthecellsurfaceasaMarkerofapoptosishavebecomecommerciallyavailable.Forthisstainingmethoditisessentialtoaddadeadcelldiscriminationdyelikepropidiumiodideor7-amino-actinomycinDtothestainedcells,becauselateapoptoticornecroticcellsalsoexpressphosphatidylserineandhavetobedistinguishedfromtheearlyapoptoticcellsbyfluorescence(13).ThenewestflowcytometricassaysmeasureCaspase-3activity,anearlymarkerofcellsundergoingapoptosisandkitsforperformingthisassaysarecommerciallyavailable(14). Pleasekeepinmindthatnotallmethodsfordetectionofapoptosisincellsmaybeequallysensitiveandtechniquesmustbeassessedcriticallywithrespecttotheirapplicabilitytoaparticularcelltypeorsystem.ProtocolfortheuseofactinomycinD(AD)onsamplesthatwerestainedwith7-AADforapoptosisandfixedinformaldehyde.